Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Annales De Biologie Clinique
|
October 25, 2001
[Nosocomial infections caused by hepatitis B virus]
V Thibault
Pathologie-Biologie
|
October 7, 2008
[Characteristics of hepatitis B viral strains in chronic carrier patients from North-East Algeria]
F Khelifa, V Thibault
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 1, 1996
Characterization and biologic activities of recombinant rat soluble interleukin-6 receptor
V Thibault, B Terlain, J Gauldie
Journal of Viral Hepatitis
|
March 5, 2003
The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C
R P Myers, V Thibault, T Poynard
Pathologie-Biologie
|
February 1, 1993
[Interleukin-1 and regulation of glucose homeostasis]
V Thibault, B Terlain, O G Ekindjian
Molecular Medicine (Cambridge, Mass.)
|
August 1, 1997
Construction and characterization of a replication-deficient adenovirus expressing rat-soluble interleukin-6 receptor
V Thibault, B Terlain, F L Graham, et al.
FEBS Letters
|
May 19, 1997
Antibodies to rat soluble IL-6 receptor stimulate B9 hybridoma cell proliferation
V Thibault, C D Richards, F Botelho, et al.
Journal of Clinical Microbiology
|
June 8, 2006
Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection
V Avettand-Fenoel, D Thabut, C Katlama, et al.
La Revue De Medecine Interne
|
September 6, 2011
[Management of the risk of hepatitis B virus reactivation in patients receiving immunosuppressive and immunomodulatory agents in internal medicine: data from the REACTI-B survey and proposal for a management algorithm]
B Terrier, S Pol, V Thibault, et al.
The Journal of Infectious Diseases
|
July 17, 2009
Natural variability of NS3 protease in patients infected with genotype 4 hepatitis C virus (HCV): implications for antiviral treatment using specifically targeted antiviral therapy for HCV
S Akhavan, A Schnuriger, P Lebray, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Annales De Biologie Clinique
|
October 25, 2001
[Nosocomial infections caused by hepatitis B virus]
V Thibault
Pathologie-Biologie
|
October 7, 2008
[Characteristics of hepatitis B viral strains in chronic carrier patients from North-East Algeria]
F Khelifa, V Thibault
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 1, 1996
Characterization and biologic activities of recombinant rat soluble interleukin-6 receptor
V Thibault, B Terlain, J Gauldie
Journal of Viral Hepatitis
|
March 5, 2003
The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C
R P Myers, V Thibault, T Poynard
Pathologie-Biologie
|
February 1, 1993
[Interleukin-1 and regulation of glucose homeostasis]
V Thibault, B Terlain, O G Ekindjian
Molecular Medicine (Cambridge, Mass.)
|
August 1, 1997
Construction and characterization of a replication-deficient adenovirus expressing rat-soluble interleukin-6 receptor
V Thibault, B Terlain, F L Graham, et al.
FEBS Letters
|
May 19, 1997
Antibodies to rat soluble IL-6 receptor stimulate B9 hybridoma cell proliferation
V Thibault, C D Richards, F Botelho, et al.
Journal of Clinical Microbiology
|
June 8, 2006
Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection
V Avettand-Fenoel, D Thabut, C Katlama, et al.
La Revue De Medecine Interne
|
September 6, 2011
[Management of the risk of hepatitis B virus reactivation in patients receiving immunosuppressive and immunomodulatory agents in internal medicine: data from the REACTI-B survey and proposal for a management algorithm]
B Terrier, S Pol, V Thibault, et al.
The Journal of Infectious Diseases
|
July 17, 2009
Natural variability of NS3 protease in patients infected with genotype 4 hepatitis C virus (HCV): implications for antiviral treatment using specifically targeted antiviral therapy for HCV
S Akhavan, A Schnuriger, P Lebray, et al.
Page
of 7